Shanwaishan (688410.SH) announced semi-annual results, with net profit of 94.37 million yuan to mother, an increase of 71.46% over the previous year

Zhitong Finance App News, Shanwaishan (688410.SH) disclosed the 2026 semi-annual report. During the reporting period, the company achieved operating income of 464 million yuan, an increase of 29.80%; net profit attributable to shareholders of listed companies was 94.37 million yuan, an increase of 71.46% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 84.98 million yuan, an increase of 67.56% year on year; the company plans to distribute a cash dividend of 2 yuan (tax included) for every 10 shares.

The main reasons for the increase in performance are: 1. As a leading enterprise of domestic blood purification equipment, the company's product market share continued to increase, driving a steady increase in the sales revenue of blood purification equipment; 2. During the reporting period, the company's self-produced blood purification consumables sales revenue increased dramatically; 3. As production and sales increased, the fixed cost of self-produced consumables units decreased further, gross margin increased, and the overall profitability of the company was further strengthened.